646 related articles for article (PubMed ID: 24819956)
1. Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.
Xie W; Xie S; Zhou Y; Tang X; Liu J; Yang W; Qiu M
Eur J Med Chem; 2014 Jun; 81():22-7. PubMed ID: 24819956
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
3. Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines.
Vandresen F; Falzirolli H; Almeida Batista SA; da Silva-Giardini AP; de Oliveira DN; Catharino RR; Ruiz AL; de Carvalho JE; Foglio MA; da Silva CC
Eur J Med Chem; 2014 May; 79():110-6. PubMed ID: 24727464
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents.
Taşdemir D; Karaküçük-İyidoğan A; Ulaşli M; Taşkin-Tok T; Oruç-Emre EE; Bayram H
Chirality; 2015 Feb; 27(2):177-88. PubMed ID: 25399965
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 1,5-benzodiazepine-2,4-dione derivatives as potential anticancer agents.
Chen Y; Le V; Xu X; Shao X; Liu J; Li Z
Bioorg Med Chem Lett; 2014 Aug; 24(16):3948-51. PubMed ID: 25017036
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
[TBL] [Abstract][Full Text] [Related]
7. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of thiophene-thiosemicarbazone derivatives and evaluation of their in vitro and in vivo antitumor activities.
de Oliveira JF; da Silva AL; Vendramini-Costa DB; da Cruz Amorim CA; Campos JF; Ribeiro AG; Olímpio de Moura R; Neves JL; Ruiz AL; Ernesto de Carvalho J; Alves de Lima Mdo C
Eur J Med Chem; 2015 Nov; 104():148-56. PubMed ID: 26454648
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
Hu K; Yang ZH; Pan SS; Xu HJ; Ren J
Eur J Med Chem; 2010 Aug; 45(8):3453-8. PubMed ID: 20494492
[TBL] [Abstract][Full Text] [Related]
10. Novel thiosemicarbazone derivatives as potential antitumor agents: Synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity.
Dilović I; Rubcić M; Vrdoljak V; Kraljević Pavelić S; Kralj M; Piantanida I; Cindrić M
Bioorg Med Chem; 2008 May; 16(9):5189-98. PubMed ID: 18358728
[TBL] [Abstract][Full Text] [Related]
11. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay.
de Oliveira JF; Lima TS; Vendramini-Costa DB; de Lacerda Pedrosa SCB; Lafayette EA; da Silva RMF; de Almeida SMV; de Moura RO; Ruiz ALTG; de Carvalho JE; de Lima MDCA
Eur J Med Chem; 2017 Aug; 136():305-314. PubMed ID: 28505535
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells.
Altintop MD; Sever B; Özdemir A; Kuş G; Oztopcu-Vatan P; Kabadere S; Kaplancikli ZA
J Enzyme Inhib Med Chem; 2016; 31(3):410-6. PubMed ID: 25826149
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluations of novel pyridone-thiazole hybrid molecules as antitumor agents.
Xie W; Wu Y; Zhang J; Mei Q; Zhang Y; Zhu N; Liu R; Zhang H
Eur J Med Chem; 2018 Feb; 145():35-40. PubMed ID: 29316536
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer agents.
Altıntop MD; Atlı Ö; Ilgın S; Demirel R; Özdemir A; Kaplancıklı ZA
Eur J Med Chem; 2016 Jan; 108():406-414. PubMed ID: 26706351
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, Cytotoxic Screening and Molecular Docking Studies of Novel Hybrid Thiosemicarbazone Derivatives as Anticancer Agents.
Mohammed FZ; Rizzk YW; El Deen IM; Mourad AAE; El Behery M
Chem Biodivers; 2021 Dec; 18(12):e2100580. PubMed ID: 34699127
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anticancer activity of novel nopinone-based thiosemicarbazone derivatives.
Wang Y; Gu W; Shan Y; Liu F; Xu X; Yang Y; Zhang Q; Zhang Y; Kuang H; Wang Z; Wang S
Bioorg Med Chem Lett; 2017 Jun; 27(11):2360-2363. PubMed ID: 28431878
[TBL] [Abstract][Full Text] [Related]
20. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
